O	0	3	The
O	4	16	Relationship
O	17	19	of
B-Characteristic	20	27	Retinal
I-Characteristic	28	34	Vessel
I-Characteristic	35	44	Geometric
I-Characteristic	45	60	Characteristics
O	61	63	to
O	64	67	the
O	68	77	Incidence
O	78	81	and
O	82	93	Progression
O	94	96	of
B-Disease	97	105	Diabetic
I-Disease	106	117	Retinopathy
O	117	118	.

O	120	122	To
O	123	130	examine
O	131	134	the
O	135	148	relationships
O	149	151	of
B-Characteristic	152	159	retinal
I-Characteristic	160	166	vessel
I-Characteristic	167	176	geometric
I-Characteristic	177	192	characteristics
O	193	194	(
B-Characteristic	194	199	RVGCs
O	199	200	)
O	201	203	to
O	204	207	the
O	208	217	incidence
O	218	221	and
O	222	233	progression
O	234	236	of
B-Disease	237	245	diabetic
I-Disease	246	257	retinopathy
O	258	259	(
B-Disease	259	261	DR
O	261	262	)
O	262	263	.

O	264	277	Observational
O	277	278	,
O	279	290	prospective
O	291	297	cohort
O	298	303	study
O	303	304	.

O	305	309	Nine
O	310	317	hundred
O	318	324	ninety
O	324	325	-
O	325	328	six
O	329	336	persons
O	337	341	with
B-Disease	342	346	type
I-Disease	347	348	1
I-Disease	349	357	diabetes
I-Disease	358	366	mellitus
O	367	368	(
B-Disease	368	372	T1DM
O	372	373	)
O	374	377	and
O	378	382	1370
O	383	390	persons
O	391	395	with
B-Disease	396	400	type
I-Disease	401	402	2
I-Disease	403	411	diabetes
I-Disease	412	420	mellitus
O	421	422	(
B-Disease	422	426	T2DM
O	426	427	)
O	428	432	seen
O	433	435	at
O	436	437	a
O	438	446	baseline
O	447	458	examination
O	459	462	who
O	463	467	were
O	468	476	eligible
O	477	480	for
O	481	487	follow
O	487	488	-
O	488	490	up
O	491	503	examinations
O	504	506	at
O	507	517	subsequent
O	518	519	5
O	519	520	-
O	520	524	year
O	525	534	intervals
O	534	535	.

O	536	537	A
O	538	543	total
O	544	546	of
O	547	551	3846
O	552	558	person
O	558	559	-
O	559	567	interval
O	568	572	data
O	573	577	from
O	578	583	these
O	584	590	follow
O	590	591	-
O	591	593	up
O	594	606	examinations
O	607	610	are
O	611	614	the
O	615	620	basis
O	621	624	for
O	625	628	the
O	629	637	analyses
O	637	638	.

B-Disease	639	647	Diabetic
I-Disease	648	659	retinopathy
O	660	663	and
B-Disease	664	671	macular
I-Disease	672	677	edema
O	678	682	were
O	683	691	assessed
O	692	694	by
O	695	702	grading
O	703	705	of
B-Diagnostic_tool	706	708	30
I-Diagnostic_tool	708	709	Â°
I-Diagnostic_tool	710	722	stereoscopic
I-Diagnostic_tool	723	728	color
I-Diagnostic_tool	729	735	fundus
I-Diagnostic_tool	736	747	photographs
O	747	748	.

B-Characteristic	749	756	Retinal
I-Characteristic	757	763	vessel
I-Characteristic	764	773	geometric
I-Characteristic	774	789	characteristics
O	790	794	were
O	795	803	assessed
O	804	809	using
O	810	813	the
O	814	823	Singapore
O	824	825	I
O	826	832	Vessel
O	833	843	Assessment
O	844	851	program
O	852	856	from
O	857	858	a
O	859	868	digitized
O	869	873	copy
O	874	876	of
O	877	878	1
O	879	881	of
O	882	885	the
O	886	891	field
O	892	893	1
B-Diagnostic_tool	894	900	fundus
I-Diagnostic_tool	901	912	photographs
O	913	921	obtained
O	922	924	at
O	925	933	baseline
O	934	937	and
O	938	944	follow
O	944	945	-
O	945	947	up
O	947	948	.

O	949	952	The
O	953	954	5
O	954	955	-
O	955	959	year
O	960	969	incidence
O	970	972	of
O	973	976	any
B-Disease	977	979	DR
O	979	980	,
O	981	992	progression
O	993	995	of
B-Disease	996	998	DR
O	998	999	,
O	1000	1003	and
O	1004	1013	incidence
O	1014	1016	of
B-Disease	1017	1030	proliferative
I-Disease	1031	1039	diabetic
I-Disease	1040	1051	retinopathy
O	1052	1053	(
B-Disease	1053	1056	PDR
O	1056	1057	)
O	1058	1061	and
B-Disease	1062	1072	clinically
I-Disease	1073	1084	significant
I-Disease	1085	1092	macular
I-Disease	1093	1098	edema
O	1099	1100	(
B-Disease	1100	1104	CSME
O	1104	1105	)
O	1106	1108	in
O	1109	1114	right
B-Anatomy	1115	1119	eyes
O	1119	1120	.

O	1121	1129	Incident
B-Disease	1130	1132	DR
O	1133	1141	occurred
O	1142	1144	in
O	1145	1147	45
O	1147	1148	%
O	1148	1149	,
O	1150	1161	progression
O	1162	1164	in
O	1165	1167	32
O	1167	1168	%
O	1168	1169	,
B-Disease	1170	1173	PDR
O	1174	1176	in
O	1177	1179	10
O	1179	1180	%
O	1180	1181	,
O	1182	1185	and
B-Disease	1186	1190	CSME
O	1191	1193	in
O	1194	1195	5
O	1195	1196	%
O	1196	1197	.

O	1198	1203	While
O	1204	1213	adjusting
O	1214	1217	for
O	1218	1226	glycated
O	1227	1237	hemoglobin
O	1237	1238	,
O	1239	1247	duration
O	1248	1250	of
B-Disease	1251	1259	diabetes
O	1259	1260	,
O	1261	1264	and
O	1265	1270	other
O	1271	1278	factors
O	1278	1279	,
B-Characteristic	1280	1287	retinal
I-Characteristic	1288	1298	arteriolar
I-Characteristic	1299	1305	simple
I-Characteristic	1306	1316	tortuosity
O	1317	1320	was
O	1321	1331	associated
O	1332	1345	significantly
O	1346	1350	with
O	1351	1354	the
O	1355	1364	incidence
O	1365	1367	of
O	1368	1371	any
B-Disease	1372	1374	DR
O	1375	1376	(
O	1376	1380	odds
O	1381	1386	ratio
O	1387	1388	[
O	1388	1390	OR
O	1390	1391	]
O	1391	1392	,
O	1393	1394	1
O	1394	1395	.
O	1395	1397	17
O	1397	1398	;
O	1399	1401	95
O	1401	1402	%
O	1403	1413	confidence
O	1414	1422	interval
O	1423	1424	[
O	1424	1426	CI
O	1426	1427	]
O	1428	1429	,
O	1430	1431	1
O	1431	1432	.
O	1432	1434	01
O	1434	1435	-
O	1435	1436	1
O	1436	1437	.
O	1437	1439	35
O	1439	1440	)
O	1440	1441	.

B-Characteristic	1442	1449	Retinal
I-Characteristic	1450	1457	venular
I-Characteristic	1458	1467	branching
I-Characteristic	1468	1473	angle
O	1474	1477	was
O	1478	1488	associated
O	1489	1502	significantly
O	1503	1507	with
O	1508	1519	progression
O	1520	1522	of
B-Disease	1523	1525	DR
O	1526	1527	(
O	1527	1529	OR
O	1529	1530	,
O	1531	1532	1
O	1532	1533	.
O	1533	1535	18
O	1535	1536	;
O	1537	1539	95
O	1539	1540	%
O	1541	1543	CI
O	1543	1544	,
O	1545	1546	1
O	1546	1547	.
O	1547	1549	03
O	1549	1550	-
O	1550	1551	1
O	1551	1552	.
O	1552	1554	36
O	1554	1555	)
O	1555	1556	,
B-Characteristic	1557	1564	retinal
I-Characteristic	1565	1572	venular
I-Characteristic	1573	1582	curvature
I-Characteristic	1583	1593	tortuosity
O	1594	1597	was
O	1598	1608	associated
O	1609	1622	significantly
O	1623	1627	with
O	1628	1631	the
O	1632	1641	incidence
O	1642	1644	of
B-Disease	1645	1648	PDR
O	1649	1650	(
O	1650	1652	OR
O	1652	1653	,
O	1654	1655	1
O	1655	1656	.
O	1656	1658	15
O	1658	1659	;
O	1660	1662	95
O	1662	1663	%
O	1664	1666	CI
O	1666	1667	,
O	1668	1669	1
O	1669	1670	.
O	1670	1672	01
O	1672	1673	-
O	1673	1674	1
O	1674	1675	.
O	1675	1677	30
O	1677	1678	)
O	1678	1679	,
O	1680	1683	and
B-Characteristic	1684	1691	retinal
I-Characteristic	1692	1699	venular
I-Characteristic	1700	1709	branching
I-Characteristic	1710	1715	angle
O	1716	1717	(
O	1717	1719	OR
O	1719	1720	,
O	1721	1722	1
O	1722	1723	.
O	1723	1725	41
O	1725	1726	;
O	1727	1729	95
O	1729	1730	%
O	1731	1733	CI
O	1733	1734	,
O	1735	1736	1
O	1736	1737	.
O	1737	1739	10
O	1739	1740	-
O	1740	1741	1
O	1741	1742	.
O	1742	1744	82
O	1744	1745	)
O	1746	1749	was
O	1750	1760	associated
O	1761	1774	significantly
O	1775	1779	with
O	1780	1783	the
O	1784	1793	incidence
O	1794	1796	of
B-Disease	1797	1801	CSME
O	1801	1802	.

O	1803	1808	There
O	1809	1813	were
O	1814	1816	no
O	1817	1828	significant
O	1829	1841	associations
O	1842	1844	of
O	1845	1850	other
B-Characteristic	1851	1856	RVGCs
O	1857	1861	with
O	1862	1865	any
O	1866	1868	of
O	1869	1872	the
B-Disease	1873	1875	DR
O	1876	1884	outcomes
O	1885	1887	in
O	1888	1891	the
O	1892	1896	full
O	1897	1909	multivariate
O	1910	1915	model
O	1915	1916	.

O	1917	1926	Inclusion
O	1927	1929	of
O	1930	1933	all
O	1934	1942	possible
B-Characteristic	1943	1948	RVGCs
O	1949	1952	did
O	1953	1956	not
O	1957	1964	improve
O	1965	1968	the
O	1969	1979	predictive
O	1980	1985	value
O	1986	1988	of
O	1989	1992	the
O	1993	1999	models
O	2000	2004	that
O	2005	2012	already
O	2013	2021	included
B-Characteristic	2022	2029	retinal
I-Characteristic	2030	2036	vessel
I-Characteristic	2037	2045	diameter
O	2046	2049	and
O	2050	2058	baseline
B-Disease	2059	2061	DR
O	2062	2070	severity
O	2071	2076	level
O	2076	2077	.

B-Characteristic	2078	2085	Retinal
I-Characteristic	2086	2092	vessel
I-Characteristic	2093	2102	geometric
I-Characteristic	2103	2118	characteristics
I-Characteristic	2119	2121	of
I-Characteristic	2122	2125	the
I-Characteristic	2126	2133	retinal
I-Characteristic	2134	2141	venules
O	2142	2146	were
O	2147	2157	associated
O	2158	2162	with
O	2163	2174	progression
O	2175	2177	of
B-Disease	2178	2180	DR
O	2180	2181	;
O	2182	2189	however
O	2189	2190	,
O	2191	2195	most
O	2196	2198	of
O	2199	2202	the
B-Characteristic	2203	2208	RVGCs
O	2209	2217	measured
O	2218	2222	from
B-Diagnostic_tool	2223	2232	digitized
I-Diagnostic_tool	2233	2239	fundus
I-Diagnostic_tool	2240	2251	photographs
O	2252	2257	added
O	2258	2264	little
O	2265	2267	to
O	2268	2271	the
O	2272	2282	assessment
O	2283	2285	of
O	2286	2290	risk
O	2291	2293	of
O	2294	2303	incidence
O	2304	2307	and
O	2308	2319	progression
O	2320	2322	of
B-Disease	2323	2325	DR
O	2326	2330	when
O	2331	2336	other
O	2337	2341	risk
O	2342	2349	factors
O	2350	2354	were
O	2355	2365	considered
O	2366	2368	in
B-Disease	2369	2373	T1DM
O	2374	2377	and
B-Disease	2378	2382	T2DM
O	2382	2383	.
